<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-07T13:02:15Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8325072" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8325072</identifier>
        <datestamp>2021-08-19</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="pmc">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8325072</article-id>
              <article-id pub-id-type="pmcid">PMC8325072</article-id>
              <article-id pub-id-type="pmc-uid">8325072</article-id>
              <article-id pub-id-type="pmid">34328501</article-id>
              <article-id pub-id-type="pmid">34328501</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2021.18516</article-id>
              <article-id pub-id-type="publisher-id">zoi210551</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Psychiatry</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Cost-effectiveness of Internet-Delivered vs In-Person Cognitive Behavioral Therapy for Children and Adolescents With Obsessive-Compulsive Disorder</article-title>
                <alt-title alt-title-type="headline">Internet-Delivered vs In-Person CBT for Children and Adolescents With OCD</alt-title>
                <alt-title alt-title-type="running-head">Internet-Delivered vs In-Person CBT for Children and Adolescents With OCD</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Aspvall</surname>
                    <given-names>Kristina</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="zoi210551aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sampaio</surname>
                    <given-names>Filipa</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lenhard</surname>
                    <given-names>Fabian</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Melin</surname>
                    <given-names>Karin</given-names>
                  </name>
                  <degrees>RN</degrees>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff4">
                    <sup>4</sup>
                  </xref>
                  <xref ref-type="aff" rid="zoi210551aff5">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Norlin</surname>
                    <given-names>Lisa</given-names>
                  </name>
                  <degrees>MSc</degrees>
                  <xref ref-type="aff" rid="zoi210551aff5">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Serlachius</surname>
                    <given-names>Eva</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="zoi210551aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mataix-Cols</surname>
                    <given-names>David</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="zoi210551aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Andersson</surname>
                    <given-names>Erik</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="zoi210551aff6">
                    <sup>6</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zoi210551aff1"><label>1</label>Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Sweden</aff>
              <aff id="zoi210551aff2"><label>2</label>Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden</aff>
              <aff id="zoi210551aff3"><label>3</label>Department of Public Health and Caring Sciences, Uppsala Universitet, Uppsala, Sweden</aff>
              <aff id="zoi210551aff4"><label>4</label>Institute Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</aff>
              <aff id="zoi210551aff5"><label>5</label>Region Västra Götaland, Department of Child and Adolescent Psychiatry, Sahlgrenska University Hospital, Gothenburg, Sweden</aff>
              <aff id="zoi210551aff6"><label>6</label>Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> May 16, 2021.</p>
                <p content-type="published-online"><bold>Published:</bold> July 30, 2021. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2021.18516</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions">CC-BY License</ext-link>. © 2021 Aspvall K et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zoi210551cor1"><bold>Corresponding Author:</bold> Erik Andersson, PhD, Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Nobels väg 9, 171 65 Stockholm, Sweden (<email xlink:href="erik.m.andersson@ki.se">erik.m.andersson@ki.se</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Aspvall and Serlachius had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p>
                <p><italic>Concept and design:</italic> Aspvall, Sampaio, Serlachius, Mataix-Cols, Andersson.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> All authors.</p>
                <p><italic>Drafting of the manuscript:</italic> Aspvall, Lenhard, Serlachius, Andersson.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> All authors.</p>
                <p><italic>Statistical analysis:</italic> Aspvall, Sampaio, Lenhard, Andersson.</p>
                <p><italic>Obtained funding:</italic> Aspvall, Melin, Serlachius, Mataix-Cols, Andersson.</p>
                <p><italic>Administrative, technical, or material support:</italic> Aspvall, Melin, Norlin, Serlachius, Andersson.</p>
                <p><italic>Supervision:</italic> Lenhard, Serlachius, Mataix-Cols, Andersson.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Drs Aspvall, Sampaio, Lenhard, Melin, Serlachius, Mataix-Cols, and Andersson and Ms Norlin reported receiving grants from the Swedish Research Council for Health, Working Life and Welfare, the ALF Medicin Project by Region Stockholm, Drottning Silvias Jubileumsfond, Fonden för psykisk hälsa, Fredrik och Ingrid Thurings stiftelse, and the Jane and Dan Olssons Foundation during the conduct of the study. Dr Mataix-Cols reported receiving personal fees from UpToDate, Wolters Kluwer Health, and Elsevier outside the submitted work. Dr Andersson reported receiving royalties from Natur &amp; Kultur unrelated to the current work. No other disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This study was funded by grant 2014-4052 from the Swedish Research Council for Health, Working Life and Welfare; grant 20160247 from the ALF Medicin Project Grant by Region Stockholm; and grant 2016-64 from the Jane and Dan Olssons Foundation. Dr Aspvall was supported by grants from Drottning Silvias Jubileumsfond, Fonden för psykisk hälsa, and Fredrik och Ingrid Thurings stiftelse. Dr Serlachius was supported by Region Stockholm (clinical research appointment, grant 20170605).</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p><bold>Additional Contributions:</bold> We thank Inna Feldman, PhD, Uppsala Universitet, for her valuable feedback on the manuscript. She was compensated in the form of a subcontract with Uppsala University.</p>
                <p><bold>Additional Information:</bold> This work used the BASS platform from the eHealth Core Facility at Karolinska Institutet, which is supported by the Strategic Research Area Healthcare Science (SFO-V).</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2021-07-30T10:00">
                <day>30</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>30</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
              <volume>4</volume>
              <issue>7</issue>
              <elocation-id>e2118516</elocation-id>
              <history>
                <date date-type="received">
                  <day>13</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>16</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2021 Aspvall K et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2118516.pdf">jamanetwopen-e2118516.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.18516"/>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-zoi210551-1">
                  <title>Question</title>
                  <p>Is internet-delivered cognitive behavioral therapy followed by face-to-face treatment for nonresponders a cost-effective alternative to in-person cognitive behavioral therapy alone for children and adolescents with obsessive-compulsive disorder?</p>
                </sec>
                <sec id="ab-zoi210551-2">
                  <title>Findings</title>
                  <p>In this economic evaluation of a randomized clinical trial including 152 children and adolescents with obsessive-compulsive disorder, internet-delivered cognitive behavioral therapy followed by face-to-face treatment for nonresponders was associated with reduced costs compared with traditional in-person cognitive behavioral therapy alone, without impairing effectiveness.</p>
                </sec>
                <sec id="ab-zoi210551-3">
                  <title>Meaning</title>
                  <p>This study suggests that a stepped-care model of cognitive behavioral therapy delivery may be cost-effective for young people with obsessive-compulsive disorder.</p>
                </sec>
              </abstract>
              <abstract>
                <sec id="ab-zoi210551-4">
                  <title>Importance</title>
                  <p>Therapist-guided, internet-delivered cognitive behavioral therapy is an effective treatment option for children and adolescents with obsessive-compulsive disorder, but to our knowledge, its cost-effectiveness compared with traditional in-person treatment has not been established.</p>
                </sec>
                <sec id="ab-zoi210551-5">
                  <title>Objective</title>
                  <p>To evaluate the cost-effectiveness of guided internet-delivered cognitive behavioral therapy implemented within a stepped-care model compared with in-person cognitive behavioral therapy for young people with obsessive-compulsive disorder.</p>
                </sec>
                <sec id="ab-zoi210551-6">
                  <title>Design, Setting, and Participants</title>
                  <p>This economic evaluation of a randomized noninferiority trial conducted at 2 specialist obsessive-compulsive disorder clinics in Sweden enrolled 152 children and adolescents aged 8 to 17 years with obsessive-compulsive disorder, mainly through clinician referrals (110 [72%]). Recruitment began October 6, 2017, and ended May 24, 2019. Follow-up ended April 14, 2020.</p>
                </sec>
                <sec id="ab-zoi210551-7">
                  <title>Interventions</title>
                  <p>Participants were randomly assigned to receive either guided internet-delivered cognitive behavioral therapy or in-person cognitive behavioral therapy during a 16-week period. At the 3-month follow-up, nonresponders in both groups were offered additional in-person cognitive behavior therapy sessions.</p>
                </sec>
                <sec id="ab-zoi210551-8">
                  <title>Main Outcomes and Measures</title>
                  <p>Health outcomes were treatment response rates (primary outcome), remission rates, and quality-adjusted life-years. Cost data were collected before treatment, after treatment, at 3-month follow-up, and at 6-month follow-up (primary end point) and are presented in 2020 US dollars. The differences in incremental costs and health outcomes were compared between the groups and presented from the health care professional, health care sector, and societal perspectives.</p>
                </sec>
                <sec id="ab-zoi210551-9">
                  <title>Results</title>
                  <p>A total of 152 participants (94 girls [62%]; mean [SD] age, 13.4 [2.5] years) were randomized; 151 (99%) completed the trial. At the 6-month follow-up, 50 of 74 participants (68%) in the stepped-care group and 52 of 77 participants (68%) in the in-person cognitive behavioral therapy group were classified as treatment responders (odds ratio, 1.00 [95% CI, 0.51-1.98]; <italic>P</italic> = .99). Health economic analyses showed that the stepped-care group used fewer therapist resources than the in-person cognitive behavioral therapy group, resulting in a mean cost savings of $2104 (95% CI, $1202-$3006) per participant for the full study period of 10 months, corresponding to a relative savings of 39%. The cost savings remained largely comparable when taking wider health care sector and societal perspectives.</p>
                </sec>
                <sec id="ab-zoi210551-10">
                  <title>Conclusions and Relevance</title>
                  <p>This study suggests that, for young people with obsessive-compulsive disorder, a low-cost digital intervention followed by in-person treatment for nonresponders was cost-effective compared with in-person cognitive behavior therapy alone.</p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser">
                <p>This economic evaluation assesses the cost-effectiveness of guided internet-delivered cognitive behavioral therapy implemented within a stepped-care model compared with in-person cognitive behavioral therapy for young people with obsessive-compulsive disorder.</p>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZOI210551">
              <title>Introduction</title>
              <p>Obsessive-compulsive disorder (OCD) has a typical onset during childhood or adolescence<sup><xref rid="zoi210551r1" ref-type="bibr">1</xref></sup> and a lifetime prevalence of 1.3%.<sup><xref rid="zoi210551r2" ref-type="bibr">2</xref></sup> The disorder is associated with a marked loss of quality of life<sup><xref rid="zoi210551r3" ref-type="bibr">3</xref></sup> and widespread functional impairment across a number of important areas, such as education and labor market participation.<sup><xref rid="zoi210551r4" ref-type="bibr">4</xref>,<xref rid="zoi210551r5" ref-type="bibr">5</xref></sup> Obsessive-compulsive disorder is also associated with increased morbidity and premature mortality from both natural and unnatural causes.<sup><xref rid="zoi210551r6" ref-type="bibr">6</xref>,<xref rid="zoi210551r7" ref-type="bibr">7</xref>,<xref rid="zoi210551r8" ref-type="bibr">8</xref></sup></p>
              <p>The recommended first-line treatment for young people with OCD is cognitive behavioral therapy (CBT).<sup><xref rid="zoi210551r9" ref-type="bibr">9</xref>,<xref rid="zoi210551r10" ref-type="bibr">10</xref></sup> Cognitive behavioral therapy is highly effective in reducing OCD symptoms,<sup><xref rid="zoi210551r11" ref-type="bibr">11</xref></sup> is associated with no or few known adverse events,<sup><xref rid="zoi210551r12" ref-type="bibr">12</xref></sup> and its effects tend to be sustained long term.<sup><xref rid="zoi210551r13" ref-type="bibr">13</xref></sup> However, CBT for OCD is best delivered by a multidisciplinary specialist team and is therefore in short supply.<sup><xref rid="zoi210551r14" ref-type="bibr">14</xref></sup> To increase the availability of high-quality CBT, we developed a therapist- and parent-guided internet-delivered CBT program for children and adolescents with OCD. Families work their way through a series of interactive online CBT modules and receive asynchronous support from a clinician via a dedicated online platform. This low-intensity intervention has demonstrated efficacy and cost-effectiveness in 3 open studies<sup><xref rid="zoi210551r15" ref-type="bibr">15</xref>,<xref rid="zoi210551r16" ref-type="bibr">16</xref>,<xref rid="zoi210551r17" ref-type="bibr">17</xref></sup> and 1 randomized waitlist clinical superiority trial.<sup><xref rid="zoi210551r18" ref-type="bibr">18</xref>,<xref rid="zoi210551r19" ref-type="bibr">19</xref>,<xref rid="zoi210551r20" ref-type="bibr">20</xref></sup> In a subsequent randomized noninferiority clinical trial,<sup><xref rid="zoi210551r19" ref-type="bibr">19</xref>,<xref rid="zoi210551r20" ref-type="bibr">20</xref></sup> 152 children and adolescents with OCD were randomly assigned to receive either internet-delivered CBT or in-person CBT during a 16-week period. At the 3-month follow-up, nonresponders in both groups were offered additional in-person CBT sessions. At the primary end point (6-month follow-up), there was a noninferior difference in OCD symptom severity between the groups. Because more than 50% of participants randomly assigned to receive internet-delivered CBT were classed as treatment responders and did not require additional in-person CBT, we hypothesized that the stepped-care approach would result in cost savings without impairing effectiveness. This study formally tested this hypothesis via a health economic evaluation of our noninferiority trial, as prespecified in the study protocol.<sup><xref rid="zoi210551r19" ref-type="bibr">19</xref>,<xref rid="zoi210551r20" ref-type="bibr">20</xref></sup></p>
            </sec>
            <sec id="H1-2-ZOI210551">
              <title>Methods</title>
              <sec id="H2-1-ZOI210551">
                <title>Study Design</title>
                <p>This study is a randomized clinical noninferiority trial with an embedded health economic evaluation for children and adolescents with OCD (N = 152) comparing stepped-care CBT (n = 74) with in-person CBT alone (n = 78). Recruitment began October 6, 2017, and ended May 24, 2019. Follow-up ended April 14, 2020. Blinded clinician assessments were conducted before treatment, after treatment, at 3-month follow-up, and at 6-month follow-up (primary end point). The study protocol<sup><xref rid="zoi210551r21" ref-type="bibr">21</xref></sup> and primary efficacy results<sup><xref rid="zoi210551r22" ref-type="bibr">22</xref></sup> have been published elsewhere. The study participant flow is presented in eFigure 1 in the <xref ref-type="supplementary-material" rid="note-ZOI210551-1-s">Supplement</xref>. The study was approved by the Regional Ethical Review Board in Stockholm, Sweden, and all participants and their parents or legal guardians provided verbal and written informed consent prior to inclusion (ClinicalTrials.gov Identifier: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03263546">NCT03263546</ext-link>). This study followed the Consolidated Health Economic Evaluation Reporting Standards (<ext-link ext-link-type="uri" xlink:href="http://www.equator-network.org/reporting-guidelines/cheers/">CHEERS</ext-link>) reporting guideline.<sup><xref rid="zoi210551r23" ref-type="bibr">23</xref></sup></p>
              </sec>
              <sec id="H2-2-ZOI210551">
                <title>Participants</title>
                <p>Participants were 152 children and adolescents recruited from 2 specialist pediatric OCD clinics in Stockholm and Gothenburg, Sweden. Families could also self-refer to the study via a dedicated study website. Eligible participants were children and adolescents who had a primary diagnosis of OCD according to the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (Fifth Edition)<italic>,</italic><sup><xref rid="zoi210551r24" ref-type="bibr">24</xref></sup> had a total score of 16 or more on the Children’s Yale-Brown Obsessive-Compulsive Scale (scores range from 0 to 40, with higher scores indicating more severe symptoms),<sup><xref rid="zoi210551r25" ref-type="bibr">25</xref></sup> were between 7 and 17 years of age, were able to read and write Swedish, and had daily access to a computer with an internet connection. Participants taking psychotropic medication were required to have had a stable dose during the 6 weeks prior to inclusion. Comorbid conditions were allowed, except for organic brain disorder, global learning disabilities, autism spectrum disorder, bipolar disorder, psychosis, or severe eating disorder. Patients were excluded if they had suicidal ideation, were housebound or in need of intensive or inpatient treatment, had completed a course of CBT for OCD within the last 12 months, or had ongoing psychological treatment for OCD or an anxiety disorder. Detailed information on the study sample is presented in <xref rid="zoi210551t1" ref-type="table">Table 1</xref>.</p>
                <table-wrap id="zoi210551t1" orientation="portrait" position="float">
                  <label>Table 1. </label>
                  <caption>
                    <title>Sociodemographic and Clinical Characteristics of the Sample</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="39.57%" span="1"/>
                    <col width="28.92%" span="1"/>
                    <col width="31.51%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Characteristic</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Participants, No. (%)</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Stepped-care (n = 74)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">In-person CBT (n = 78)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Girls</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">46 (62)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">48 (62)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Boys</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">28 (38)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">30 (39)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, mean (SD) [range], y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13.4 (2.6) [8-17]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13.4 (2.5) [8-17]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Educational level of parent<xref ref-type="table-fn" rid="zoi210551t1n1"><sup>a</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary school</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Secondary school</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (10)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1"> College or university</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &lt;2 y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (10)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> ≥2 y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">53 (72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60 (77)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Doctorate</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Occupational status of parent<xref ref-type="table-fn" rid="zoi210551t1n1"><sup>a</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Working</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">68 (92)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75 (96)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Student</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> On sick leave</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Comorbidity</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">50 (68)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">50 (64)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Depressive episode</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (15)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Anxiety disorders</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Specific phobia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (8)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Social phobia</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> GAD</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Panic disorder</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Separation anxiety</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Health anxiety</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Tic disorder</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (10)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> ADHD</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Eating disorder</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Medication (ongoing)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> None</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">69 (93)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">74 (95)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> SSRI</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sleep hormone</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (2)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Central stimulants</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Antihistamine</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Baseline CY-BOCS score, mean (SD) [range]<xref ref-type="table-fn" rid="zoi210551t1n2"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">22.96 (3.64) [16-32]</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">22.95 (3.70) [17-33]</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Baseline total societal costs, mean (SD), $</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3479 (3907)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3098 (3396)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Source of referral</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Clinician</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">54 (73)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56 (72)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Self</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">20 (27)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">22 (28)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CBT, cognitive behavioral therapy; CY-BOCS, Children’s Yale-Brown Obsessive-Compulsive Scale; GAD, generalized anxiety disorder; SSRI, selective serotonin-reuptake inhibitors.</p>
                    <fn id="zoi210551t1n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>The parent mainly responsible for study participation.</p>
                    </fn>
                    <fn id="zoi210551t1n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>CY-BOCS scores range from 0 to 40, with higher scores indicating more severe symptoms.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-3-ZOI210551">
                <title>Interventions</title>
                <sec id="H3-1-ZOI210551">
                  <title>Stepped-Care CBT</title>
                  <p>Participants randomly assigned to receive stepped-care treatment (n = 74) first received guided internet-delivered CBT during a 16-week period. There were separate versions of the program for children and adolescents; both consisted of 14 consecutive modules that focused on psychoeducation, exposure with response prevention, and relapse prevention. Parents had access to parallel modules that specifically addressed parental aspects of the treatment, such as family accommodation of symptoms. The families had contact with a designated therapist throughout the treatment period who responded to messages through the built-in message system, provided feedback on assignments, and helped the families when problems arose. Most of the therapist contact was asynchronous through the treatment platform, but additional telephone support was provided on demand. A more detailed description of the treatment can be found elsewhere.<sup><xref rid="zoi210551r21" ref-type="bibr">21</xref>,<xref rid="zoi210551r22" ref-type="bibr">22</xref></sup> Participants who were assessed as being nonresponders at the 3-month follow-up<sup><xref rid="zoi210551r26" ref-type="bibr">26</xref></sup> were offered up to 12 sessions of in-person CBT between the 3-month follow-up and the 6-month follow-up. The additional in-person sessions focused on exposure with response prevention according to a validated in-person CBT protocol for youths with OCD,<sup><xref rid="zoi210551r27" ref-type="bibr">27</xref></sup> with individually tailored adaptations regarding the degree of parental involvement, session length, and need for home visits.</p>
                </sec>
                <sec id="H3-2-ZOI210551">
                  <title>In-Person CBT</title>
                  <p>Participants randomly assigned to receive in-person CBT (n = 78) received face-to-face treatment during a 16-week period. The treatment consisted of up to 14 sessions of manualized CBT<sup><xref rid="zoi210551r27" ref-type="bibr">27</xref></sup> delivered by a designated therapist; the main focus was on exposure with response prevention. Adaptations based on individual needs, such as longer sessions or home visits, were made. Nonresponders at the 3-month follow-up were offered additional face-to-face treatment, as in the stepped-care CBT group. The treatment is described in detail elsewhere.<sup><xref rid="zoi210551r22" ref-type="bibr">22</xref></sup></p>
                </sec>
              </sec>
              <sec id="H2-4-ZOI210551">
                <title>Health Economic Evaluation</title>
                <p>The 2 treatment groups were compared regarding health care professional costs, health care sector costs, and other societal costs in association with clinical effectiveness (cost-effectiveness analyses) and quality-adjusted life-years (QALYs; cost utility analysis). As per our protocol, the primary analysis was the cost-effectiveness analysis from the health care professional perspective using responder status at the 6-month follow-up as the health outcome. We focused mainly on the perspective of the health care professional as the payer because we expected the difference in intervention costs to be the most relevant from a policy maker perspective. However, the health care sector and societal perspectives were also included based on current recommendations.<sup><xref rid="zoi210551r28" ref-type="bibr">28</xref></sup> The reason for using responder status as the primary health outcome measure was that it is the most clinically relevant when evaluating the treatment effect in regular health care. Furthermore, responder status had a central part in the design of the trial because it determined which participants should be offered additional in-person treatment at the 3-month follow-up.</p>
                <p>For completion, we also conducted a secondary cost-effectiveness analysis using remitter status as the health outcome. A patient is regarded to be in remission when he or she no longer meets syndromal criteria for OCD and has no more than minimal symptoms.<sup><xref rid="zoi210551r26" ref-type="bibr">26</xref></sup></p>
                <sec id="H3-3-ZOI210551">
                  <title>Costs</title>
                  <p>The health care professional costs were estimated by multiplying the therapist time spent on the 2 interventions by the mean hourly licensed clinical psychologist cost in Sweden (<xref rid="zoi210551t2" ref-type="table">Table 2</xref>).<sup><xref rid="zoi210551r29" ref-type="bibr">29</xref></sup> The therapist time spent supporting families in the internet-delivered CBT treatment was recorded automatically in the platform; therapists manually recorded time spent on occasional telephone calls. The therapist time spent during in-person CBT was manually recorded by the therapist after each session and included occasional telephone calls, administration time (ie, time spent by the therapist preparing for sessions or writing notes in the electronic medical record), and travel time (ie, time spent by the therapist traveling to and from face-to-face CBT sessions outside the clinic). Detailed information on therapist time is found in the eTable in the <xref ref-type="supplementary-material" rid="note-ZOI210551-1-s">Supplement</xref>.</p>
                  <table-wrap id="zoi210551t2" orientation="portrait" position="float">
                    <label>Table 2. </label>
                    <caption>
                      <title>Unit Costs and Sources</title>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <col width="37.49%" span="1"/>
                      <col width="18.77%" span="1"/>
                      <col width="43.74%" span="1"/>
                      <thead>
                        <tr>
                          <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Resource item</th>
                          <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Unit cost, $<xref ref-type="table-fn" rid="zoi210551t2n1"><sup>a</sup></xref></th>
                          <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Source</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Healthcare resources (per visit)</td>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> General practitioner</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">202.91</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Region Stockholm</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Nurse, counselor, or physiotherapist</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">90.18</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Region Stockholm</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Specialist practitioner<xref ref-type="table-fn" rid="zoi210551t2n2"><sup>b</sup></xref></td>
                          <td valign="top" align="left" rowspan="1" colspan="1">450.22</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Sweden’s municipalities and regions</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Psychologist</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">381.24</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Sweden’s municipalities and regions</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Speech and language therapist</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">285.88</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Region Stockholm</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dietician</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">328.71</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Region Stockholm</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Medication</td>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Medicines</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Individual product prices</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">The Dental and Pharmaceutical Benefits Agency of Sweden</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dietary supplements</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Individual product prices</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Market price from Swedish pharmacy</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Support and assistance</td>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Specialist teacher</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">22.81</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Own estimate</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Study help</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">50.48</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Own estimate</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Support from family and friends</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">17.06</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Estimated as cost of leisure time</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Personal assistant</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">34.30</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Swedish Insurance Agency</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Support family</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">76.88</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Sweden’s municipalities and regions</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Productivity losses</td>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cost per child/d at school</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">82.74</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Own estimate based on Swedish National Agency for Education</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Average wage/h in Sweden<xref ref-type="table-fn" rid="zoi210551t2n3"><sup>c</sup></xref></td>
                          <td valign="top" align="left" rowspan="1" colspan="1">34.93</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Statistics Sweden</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cost of leisure time/h</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">17.06</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Posttax wage/h in Sweden<sup><xref rid="zoi210551r29" ref-type="bibr">29</xref></sup>
</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Intervention cost</td>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                          <td valign="top" align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Psychologist/h</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">381.24</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Sweden’s municipalities and regions</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <fn id="zoi210551t2n1">
                        <label>
                          <sup>a</sup>
                        </label>
                        <p>All costs uprated to 2020 US dollars.</p>
                      </fn>
                      <fn id="zoi210551t2n2">
                        <label>
                          <sup>b</sup>
                        </label>
                        <p>Based on a mean of 9 medical specialties.</p>
                      </fn>
                      <fn id="zoi210551t2n3">
                        <label>
                          <sup>c</sup>
                        </label>
                        <p>Includes social fees of 43.3%.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                  <p>For the health care sector and societal perspectives, other costs captured by the adapted parent-rated questionnaire Trimbos-iMTA questionnaire for costs associated with psychiatric illness (TiC-P)<sup><xref rid="zoi210551r30" ref-type="bibr">30</xref></sup> were added to the intervention costs. For the health care sector perspective, costs for other direct health care resources and medications were included. For the societal perspective, costs for social support and assistance, productivity losses due to school absenteeism and presenteeism (being physically present in class but with markedly reduced productivity because of OCD symptoms) for children, and productivity losses due to absence from paid and unpaid work (for parents) were also included. For both these perspectives, costs were estimated by multiplying resource use frequencies by unit costs (eMethods in the <xref ref-type="supplementary-material" rid="note-ZOI210551-1-s">Supplement</xref>; <xref rid="zoi210551t2" ref-type="table">Table 2</xref><sup><xref rid="zoi210551r29" ref-type="bibr">29</xref></sup>). The TiC-P questionnaire asked about resource use for the preceding 3 months and was completed by the parents via the online platform before treatment, after treatment, at 3-month follow-up, and at 6-month follow-up.</p>
                  <p>Costs were accumulated from baseline until 6-month follow-up by trial group (all randomized participants included). We estimated the cost for resources in 2019 Swedish krona and converted to 2020 US dollars according to the conversion rate $1 = SEK8.871 using purchasing power parities for the gross domestic product.<sup><xref rid="zoi210551r31" ref-type="bibr">31</xref></sup> No discounting was applied because the data on costs and outcomes were collected within a 1 year.</p>
                </sec>
                <sec id="H3-4-ZOI210551">
                  <title>Health Outcomes</title>
                  <p>The cost-effectiveness analyses were conducted using responder status and remitter status as primary and secondary health outcomes, respectively. Treatment response was defined as at least a 35% reduction on the Children’s Yale-Brown Obsessive-Compulsive Scale and a Clinical Global Impression–Improvement score of 1 (very much improved) or 2 (much improved). Remission was defined as a score of 12 or less on the Children’s Yale-Brown Obsessive-Compulsive Scale and a Clinical Global Impression–Severity rating of 1 (normal, not at all ill) or 2 (borderline mentally ill).<sup><xref rid="zoi210551r26" ref-type="bibr">26</xref></sup></p>
                  <p>The secondary cost-utility analysis used QALYs as the health outcome. The self-rated Child Health Utility 9 Dimensions (CHU9D)<sup><xref rid="zoi210551r32" ref-type="bibr">32</xref></sup> questionnaire was used to measure health-related quality of life and provide utility weights, which in turn were used to estimate QALYs. The CHU9D is a generic pediatric preference-based measure that includes 9 items, each with 5 response options. Total QALYs during the trial period were calculated by using the area under the curve method.<sup><xref rid="zoi210551r33" ref-type="bibr">33</xref></sup></p>
                </sec>
              </sec>
              <sec id="H2-5-ZOI210551">
                <title>Statistical Analysis</title>
                <p>Between-group differences in baseline societal costs were analyzed with the Wilcoxon rank sum test. All <italic>P</italic> values were from 2-sided tests and results were deemed statistically significant at <italic>P</italic> &lt; .05. The analysis was conducted with all participants according to randomization group. Multiple imputation by chained equations was used to account for missing data on the TiC-P and CHU9D, assuming the data were likely to be missing at random.<sup><xref rid="zoi210551r34" ref-type="bibr">34</xref></sup> Between-group differences in responder and remitter status were analyzed using a regression framework. Costs and QALYs were analyzed using generalized linear models (gamma family, log link for costs and gaussian family, identity link for QALYs) to estimate differences between groups to allow for the consideration of other distributions and functional forms to fit the data.<sup><xref rid="zoi210551r35" ref-type="bibr">35</xref></sup> Between-group differences in total costs for the health care sector perspective and the broader societal perspective were analyzed while controlling for baseline total costs, and total QALYs were analyzed while controlling for baseline CHU9D utilities.<sup><xref rid="zoi210551r36" ref-type="bibr">36</xref></sup></p>
              </sec>
              <sec id="H2-6-ZOI210551">
                <title>Cost-effectiveness Analyses</title>
                <p>As cost-effectiveness estimates of stepped-care vs in-person CBT, incremental differences between the groups in net costs and outcomes are presented from the 3 different perspectives. Cost-effectiveness planes show the uncertainty around the incremental cost and outcome estimates using nonparametric bootstrapping with 5000 iterations.<sup><xref rid="zoi210551r37" ref-type="bibr">37</xref></sup> All statistical analyses were conducted using Stata, versions 15.1 and 16.1 (StataCorp).</p>
              </sec>
            </sec>
            <sec id="H1-3-ZOI210551">
              <title>Results</title>
              <p>A total of 152 participants (94 girls [62%]; mean [SD] age, 13.4 [2.5] years) were randomized; 74 were randomly assigned to receive stepped-care treatment, and 78 to in-person CBT; 52 participants (34%) had at least 1 additional psychiatric comorbid condition (<xref rid="zoi210551t1" ref-type="table">Table 1</xref>). Most participants (110 [72%]) were referred to the study by clinicians. More detailed information about the study participants can be found in the main outcome trial<sup><xref rid="zoi210551r22" ref-type="bibr">22</xref></sup> and in <xref rid="zoi210551t1" ref-type="table">Table 1</xref>.</p>
              <sec id="H2-7-ZOI210551">
                <title>Costs</title>
                <p>For the first treatment step, the mean (SE) intervention cost was $2140 ($112) per participant for the internet-delivered CBT treatment and $4713 ($136) for the in-person treatment. At the 3-month follow-up, 34 of the 74 individuals (46%) in the stepped-care group were classified as nonresponders; 29 of these individuals accepted the offer of in-person CBT between the 3-month follow-up and 6-month follow-up, which rendered a mean (SE) cost of $3066 ($107) per patient for this additional treatment. In the in-person CBT group, 23 of 77 individuals (30%) were classified as nonresponders at the 3-month follow-up; 16 received more in-person treatment, for a mean (SE) additional cost of $3323 ($112) per patient. Thus, in total, the mean (SE) intervention cost for participants randomly assigned to the stepped-care group was $3343 ($200) per patient, and the corresponding mean (SE) intervention cost for participants randomly assigned to in-person CBT only was $5395 ($364) per patient. This resulted in a mean cost savings of $2104 (95% CI, $1202-$3006) per patient in the stepped-care group compared with the in-person CBT alone group for the whole treatment period, a relative cost savings of 39%.</p>
                <p>There was no difference in mean (SD) total societal costs between the 2 groups at baseline (stepped care, $3479 [$3907]; in-person CBT, $3098 [$3396]; <italic>P</italic> = .88; <xref rid="zoi210551t1" ref-type="table">Table 1</xref>). At the 6-month follow-up, the mean health care sector cost difference between the groups was $1688 (95% CI, $919-$2133), indicating significant cost savings for the stepped-care treatment compared with in-person CBT alone. From the societal perspective, there was a mean cost savings in the stepped-care treatment of $1748 (95% CI, $483-$2488) per patient compared with in-person CBT alone. A more detailed description of the costs during the whole trial period is presented in <xref rid="zoi210551t3" ref-type="table">Table 3</xref>.</p>
                <table-wrap id="zoi210551t3" orientation="portrait" position="float">
                  <label>Table 3. </label>
                  <caption>
                    <title>Cost and Outcomes Over the Trial Period<xref ref-type="table-fn" rid="zoi210551t3n1"><sup>a</sup></xref></title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="29.96%" span="1"/>
                    <col width="14.54%" span="1"/>
                    <col width="15.52%" span="1"/>
                    <col width="14.54%" span="1"/>
                    <col width="25.44%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Cost category</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Observed mean (SE)</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Mean difference</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Stepped-care (n = 74)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">In-person CBT (n = 78)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Unadjusted</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Adjusted (95% CI)<xref ref-type="table-fn" rid="zoi210551t3n2"><sup>b</sup></xref></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="5" valign="top" align="left" scope="col" rowspan="1">
                          <bold>Costs</bold>
                        </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Before multiple imputation</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Health care visits</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2580 (673)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2093 (300)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">485</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">59 (−176 to 666)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Support and assistance</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">406 (121)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">607 (183)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−207</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (−74 to 733)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Medication/supplements</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">83 (38)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">63 (15)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−9 (−14 to 21)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Parental unpaid productivity loss<xref ref-type="table-fn" rid="zoi210551t3n3"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1500 (616)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1541 (441)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−41</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">38 (−95 to 586)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Parental paid productivity loss<xref ref-type="table-fn" rid="zoi210551t3n4"><sup>d</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">926 (166)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1806 (429)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−937</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (−135 to 1184)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Child school absenteeism</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1091 (221)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1361 (233)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−274</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−75 (−149 to 135)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Child school presenteeism</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">905 (309)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">826 (173)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">79</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">47 (−97 to 697)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total intervention costs</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3343 (200)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5395 (364)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2104</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2104 (−3006 to −1202)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Step 1</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2140 (112)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4713 (136)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Step 2</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3066 (107)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3323 (112)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total health care costs<xref ref-type="table-fn" rid="zoi210551t3n5"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6137 (492)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7684 (404)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1569</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1688 (−2133 to −919)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total societal costs<xref ref-type="table-fn" rid="zoi210551t3n5"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 917 (1188)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 825 (1212)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2955</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1723 (−2381 to −601)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">After multiple imputation</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total health care costs<xref ref-type="table-fn" rid="zoi210551t3n5"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6081 (605)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7527 (492)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1445</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1530 (−2076 to −588)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total societal costs<xref ref-type="table-fn" rid="zoi210551t3n5"><sup>e</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 755 (1360)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 592 (1199)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2837</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1748 (−2488 to −483)</td>
                      </tr>
                      <tr>
                        <td colspan="5" valign="top" align="left" scope="col" rowspan="1">
                          <bold>Health outcomes</bold>
                        </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Responders</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.676</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.675</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.0004</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.0004 (−0.151 to 0.152)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Remitters</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.486</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.597</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.111</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.111 (−0.271 to 0.049)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total QALYs (child)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.620 (0.009)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.636 (0.008)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.017</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.029 (−0.055 to 0.006)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: CBT, cognitive behavioral therapy; QALYs, quality-adjusted life-years.</p>
                    <fn id="zoi210551t3n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Costs are for the whole trial period of 10 months and are presented in 2020 US dollars.</p>
                    </fn>
                    <fn id="zoi210551t3n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Responders, remitters, and total intervention costs were not adjusted. Adjusted mean differences for other costs were calculated using generalized linear models adjusted for baseline societal cost. Total QALYs were adjusted for baseline Child Health Utility 9 Dimensions utilities.</p>
                    </fn>
                    <fn id="zoi210551t3n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>Housework.</p>
                    </fn>
                    <fn id="zoi210551t3n4">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Work absenteeism.</p>
                    </fn>
                    <fn id="zoi210551t3n5">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>Including intervention costs.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-8-ZOI210551">
                <title>Health Outcomes at the 6-Month Follow-up</title>
                <p>At the 6-month follow-up, 50 of 74 participants (68%) in the stepped-care group and 52 of 77 participants (68%) in the in-person CBT group were classified as treatment responders (mean difference, 0.0004 [95% CI, −0.151 to 0.152]; <xref rid="zoi210551t3" ref-type="table">Table 3</xref>), corresponding to an odds ratio of 1.00 (95% CI, 0.51-1.98; <italic>P</italic> = .99). The proportion of participants in remission was 49% in the stepped-care group (36 of 74) and 60% in the in-person CBT group (46 of 77; mean difference, −0.111 [95% CI, −0.271 to 0.049]), corresponding to an odds ratio of 0.64 (95% CI, 0.34-1.22; <italic>P</italic> = .17). The adjusted mean difference in QALYs was −0.029 (95% CI, −0.055 to 0.006).</p>
              </sec>
              <sec id="H2-9-ZOI210551">
                <title>Cost-effectiveness Analyses</title>
                <p>The bootstrapped estimates of incremental costs from the 3 perspectives and the difference in treatment response were equally distributed between the southwest and southeast quadrants of the cost-effectiveness planes, indicating comparable treatment effectiveness between the groups and indicating that the stepped-care treatment was less costly than in-person CBT alone (<xref ref-type="fig" rid="zoi210551f1">Figure</xref>). The cost-effectiveness planes for the secondary outcomes (remitter status and QALYs) as the health outcomes are presented in eFigure 2 in the <xref ref-type="supplementary-material" rid="note-ZOI210551-1-s">Supplement</xref>. These analyses indicate that stepped-care treatment was less costly but also slightly less effective than in-person CBT alone.</p>
                <fig id="zoi210551f1" fig-type="figure" orientation="portrait" position="float">
                  <label>Figure. </label>
                  <caption>
                    <title>Cost-effectiveness Planes Using Responder Status as Primary Health Outcome</title>
                    <p>Cost-effectiveness planes with responder status as health outcome from the health care professional perspective (A), the health care sector perspective (B), and the societal perspective (C). Each plane has 4 quadrants. Dots in the northwest (NW) quadrant indicate that stepped care is more costly and less effective. Dots in the northeast (NE) quadrant indicate that stepped care is both more costly and more effective. Dots in the southwest (SW) quadrant indicate that stepped care is both less costly and less effective. Dots in the southeast (SE) quadrant indicate that stepped care is less costly and more effective.</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2118516-g001"/>
                </fig>
              </sec>
            </sec>
            <sec id="H1-4-ZOI210551">
              <title>Discussion</title>
              <p>The main finding of this health economic evaluation was that delivering CBT for young people with OCD in a stepped-care fashion, with in-person CBT being reserved for nonresponders to internet-delivered CBT, was cost-effective compared with delivering in-person CBT alone. The results remained largely comparable when estimated from wider health care sector and societal perspectives.</p>
              <p>As many as 54% of the patients (40 of 74) who received internet-delivered CBT were classified as treatment responders at the 3-month follow-up, amounting to a mean cost of only about $2140 per patient for the first treatment step. A significantly higher proportion (70% [53 of 76]) of participants randomly assigned to receive in-person CBT were classified as responders at the 3-month follow-up, but at a substantially higher mean cost of $4713 per patient for the first course of in-person CBT. Thus, it was possible to reduce the number of patients requiring in-person treatment by offering a low-cost intervention in the first step; this approach resulted in an overall cost savings of $2104 per patient for the whole study period compared with offering the standard face-to-face treatment alone. At the 6-month follow-up, the stepped-care and the in-person CBT groups had equal proportions of treatment responders (68%), but the stepped-care group had a relative cost reduction of 39%. Even when broadening the perspective to a wide-scale health care sector perspective including other health care resources and medications, and when using a societal perspective additionally including resources associated with social support and assistance as well as productivity losses (such as school and work absenteeism and presenteeism), the stepped-care approach remained a more cost-effective alternative. From a policy maker perspective, the results demonstrate that by stepwise increasing the intensity of CBT for those who do not respond sufficiently to internet-delivered CBT, it is possible to achieve the same effectiveness of treatment as that achieved with traditional in-person treatment, but at a significantly lower cost. The stepped-care approach could be even more cost-effective if treatment support were provided by less qualified clinicians (eg, trainee psychologists or other health professionals) instead of licensed clinical psychologists. Costly specialist clinician time may be better used to either treat more patients or to focus on patients with complex presentations.</p>
              <p>Secondary analyses indicated that the stepped-care approach was less costly but that the in-person CBT group had a slightly higher proportion of remitters than the stepped care group (60% vs 49%), a statistically nonsignificant difference. It is possible that individuals receiving stepped-care treatment have a slower trajectory to remission than those randomly assigned to receive in-person CBT. Our planned 12- and 24-month follow-up analyses will hopefully shed some light on this question. The secondary cost-utility analysis also showed that the stepped-care approach produced fewer QALYs than in-person CBT. However, this between-group difference was small (the in-person CBT group scored only 0.016 points higher on the QALY outcome questionnaire than the stepped-care group, a statistically nonsignificant difference) and probably not clinically meaningful.</p>
              <p>The only 2 previously published within-trial economic evaluations of internet-delivered CBT for OCD found that the approach was cost-effective compared with a waitlist condition for adolescents (larger proportion of responders at lower costs than the comparator)<sup><xref rid="zoi210551r18" ref-type="bibr">18</xref></sup> and compared with online supportive therapy for adults (incremental cost-effectiveness ratio; $931 per additional responder and $7186 per gained QALY).<sup><xref rid="zoi210551r38" ref-type="bibr">38</xref></sup> To our knowledge, only 1 previous study conducted a health economic evaluation of a stepped-care internet-delivered CBT model for young people with anxiety disorders.<sup><xref rid="zoi210551r39" ref-type="bibr">39</xref></sup> The present study is therefore, to our knowledge, a rare example of health economic evaluation of internet-delivered CBT for young people with psychiatric disorders in general.</p>
              <sec id="H2-10-ZOI210551">
                <title>Strengths and Limitations</title>
                <p>This study has some strengths. The main strengths included the high resolution of the intervention cost data, because the therapists’ time spent on each participant was meticulously recorded, and the long controlled study period, which captures both intervention costs and additional costs beyond posttreatment. Furthermore, the stepped-care treatment was evaluated against in-person CBT, which is the recommended first-line intervention for young people with OCD,<sup><xref rid="zoi210551r9" ref-type="bibr">9</xref>,<xref rid="zoi210551r10" ref-type="bibr">10</xref></sup> and is thus the key comparator to guide decision makers regarding implementation. Last, most of the participants were referred by a clinician, which means that our sample was likely representative of the population typically seen in mental health clinics.</p>
                <p>This study also has some limitations. The trial was conducted in Sweden, which has a tax-funded universal health system that may affect the interpretation of the results. The chosen scenario incorporated a full publicly funded health care system in which the focus is on lowering the costs for the health care professional. However, the stepped-care approach may result in delayed response to treatment for some individuals and may therefore not be the preferred choice for policy makers operating in other health care contexts with immediate access to high-quality specialist treatment for OCD. Future research should expand to other countries and health care contexts to evaluate the cost-effectiveness of stepped-care approaches from different payer perspectives in different samples. Another limitation was that other health care resources and societal costs were assessed retrospectively with a parent-reported measure. Although this method is considered valid<sup><xref rid="zoi210551r40" ref-type="bibr">40</xref></sup> and recommended in guidelines,<sup><xref rid="zoi210551r41" ref-type="bibr">41</xref></sup> an additional objective assessment could have strengthened the results further.</p>
              </sec>
            </sec>
            <sec id="H1-5-ZOI210551">
              <title>Conclusions</title>
              <p>This study suggests that a stepped-care model in which young people with OCD are first offered a low-cost digital CBT intervention followed by traditional in-person therapy for nonresponders is as effective as, and more cost-effective than, the traditional in-office treatment format. The findings provide important implications for clinical practice and health policy.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZOI210551">
              <title>References</title>
              <ref id="zoi210551r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Taylor</surname><given-names>S</given-names></string-name></person-group>. <article-title>Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes</article-title>. <source>Clin Psychol Rev</source>. <year>2011</year>;<volume>31</volume>(<issue>7</issue>):<fpage>1083</fpage>-<lpage>1100</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cpr.2011.06.007</pub-id><?supplied-pmid 21820387?><pub-id pub-id-type="pmid">21820387</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Fawcett</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Power</surname><given-names>H</given-names></string-name>, <string-name><surname>Fawcett</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide</article-title>. <source>J Clin Psychiatry</source>. <year>2020</year>;<volume>81</volume>(<issue>4</issue>):<elocation-id>19r13085</elocation-id>. doi:<pub-id pub-id-type="doi">10.4088/JCP.19r13085</pub-id><?supplied-pmid 32603559?><pub-id pub-id-type="pmid">32603559</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lack</surname><given-names>CW</given-names></string-name>, <string-name><surname>Storch</surname><given-names>EA</given-names></string-name>, <string-name><surname>Keeley</surname><given-names>ML</given-names></string-name>, <etal/></person-group>. <article-title>Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source>. <year>2009</year>;<volume>44</volume>(<issue>11</issue>):<fpage>935</fpage>-<lpage>942</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00127-009-0013-9</pub-id><?supplied-pmid 19255701?><pub-id pub-id-type="pmid">19255701</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pérez-Vigil</surname><given-names>A</given-names></string-name>, <string-name><surname>Fernández de la Cruz</surname><given-names>L</given-names></string-name>, <string-name><surname>Brander</surname><given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>Association of obsessive-compulsive disorder with objective indicators of educational attainment: a nationwide register-based sibling control study</article-title>. <source>JAMA Psychiatry</source>. <year>2018</year>;<volume>75</volume>(<issue>1</issue>):<fpage>47</fpage>-<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.3523</pub-id><?supplied-pmid 29141084?><pub-id pub-id-type="pmid">29141084</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pérez-Vigil</surname><given-names>A</given-names></string-name>, <string-name><surname>Mittendorfer-Rutz</surname><given-names>E</given-names></string-name>, <string-name><surname>Helgesson</surname><given-names>M</given-names></string-name>, <string-name><surname>Fernandez de la Cruz</surname><given-names>L</given-names></string-name>, <string-name><surname>Mataix-Cols</surname><given-names>D</given-names></string-name></person-group>. <article-title>Labour market marginalisation in obsessive–compulsive disorder: a nationwide register-based sibling control study</article-title>. <source>Psychol Med.</source><year>2019</year>;<volume>49</volume>(<issue>6</issue>):<fpage>1015</fpage>-<lpage>1024</lpage>.<?supplied-pmid 29950186?><pub-id pub-id-type="pmid">29950186</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Fernandez de la Cruz</surname><given-names>L</given-names></string-name>, <string-name><surname>Rydell</surname><given-names>M</given-names></string-name>, <string-name><surname>Runeson</surname><given-names>B</given-names></string-name>, <etal/></person-group>. <article-title>Suicide in obsessive-compulsive disorder: a population-based study of 36 788 Swedish patients</article-title>. <source>Mol Psychiatry.</source><year>2017</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1626</fpage>-<lpage>1632</lpage>.<?supplied-pmid 27431293?><pub-id pub-id-type="pmid">27431293</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Isomura</surname><given-names>K</given-names></string-name>, <string-name><surname>Brander</surname><given-names>G</given-names></string-name>, <string-name><surname>Chang</surname><given-names>Z</given-names></string-name>, <etal/></person-group>. <article-title>Metabolic and cardiovascular complications in obsessive-compulsive disorder: a total population, sibling comparison study with long-term follow-up</article-title>. <source>Biol Psychiatry</source>. <year>2018</year>;<volume>84</volume>(<issue>5</issue>):<fpage>324</fpage>-<lpage>331</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.12.003</pub-id><?supplied-pmid 29395042?><pub-id pub-id-type="pmid">29395042</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Meier</surname><given-names>SM</given-names></string-name>, <string-name><surname>Mattheisen</surname><given-names>M</given-names></string-name>, <string-name><surname>Mors</surname><given-names>O</given-names></string-name>, <string-name><surname>Schendel</surname><given-names>DE</given-names></string-name>, <string-name><surname>Mortensen</surname><given-names>PB</given-names></string-name>, <string-name><surname>Plessen</surname><given-names>KJ</given-names></string-name></person-group>. <article-title>Mortality among persons with obsessive-compulsive disorder in Denmark</article-title>. <source>JAMA Psychiatry</source>. <year>2016</year>;<volume>73</volume>(<issue>3</issue>):<fpage>268</fpage>-<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.3105</pub-id><?supplied-pmid 26818216?><pub-id pub-id-type="pmid">26818216</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r9">
                <label>9</label>
                <mixed-citation publication-type="web"><person-group><collab>National Institute for Health and Care Excellence</collab></person-group>. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. Clinical guideline [CG31. Published November 29, 2005. Accessed October 11, 2020. <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/cg31">https://www.nice.org.uk/guidance/cg31</ext-link></mixed-citation>
              </ref>
              <ref id="zoi210551r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Geller</surname><given-names>DA</given-names></string-name>, <string-name><surname>March</surname><given-names>J</given-names></string-name></person-group>. <article-title>Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2012</year>;<volume>51</volume>(<issue>1</issue>):<fpage>98</fpage>-<lpage>113</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaac.2011.09.019</pub-id><?supplied-pmid 22176943?><pub-id pub-id-type="pmid">22176943</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Öst</surname><given-names>L-G</given-names></string-name>, <string-name><surname>Riise</surname><given-names>EN</given-names></string-name>, <string-name><surname>Wergeland</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>B</given-names></string-name>, <string-name><surname>Kvale</surname><given-names>G</given-names></string-name></person-group>. <article-title>Cognitive behavioral and pharmacological treatments of OCD in children: a systematic review and meta-analysis</article-title>. <source>J Anxiety Disord</source>. <year>2016</year>;<volume>43</volume>:<fpage>58</fpage>-<lpage>69</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.janxdis.2016.08.003</pub-id><?supplied-pmid 27632568?><pub-id pub-id-type="pmid">27632568</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Uhre</surname><given-names>CF</given-names></string-name>, <string-name><surname>Uhre</surname><given-names>VF</given-names></string-name>, <string-name><surname>Lønfeldt</surname><given-names>NN</given-names></string-name>, <etal/></person-group>. <article-title>Systematic review and meta-analysis: cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2020</year>;<volume>59</volume>(<issue>1</issue>):<fpage>64</fpage>-<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaac.2019.08.480</pub-id><?supplied-pmid 31589909?><pub-id pub-id-type="pmid">31589909</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Melin</surname><given-names>K</given-names></string-name>, <string-name><surname>Skarphedinsson</surname><given-names>G</given-names></string-name>, <string-name><surname>Thomsen</surname><given-names>PH</given-names></string-name>, <etal/></person-group>. <article-title>Treatment gains are sustainable in pediatric obsessive-compulsive disorder: three-year follow-up from the NordLOTS</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2020</year>;<volume>59</volume>(<issue>2</issue>):<fpage>244</fpage>-<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaac.2019.01.010</pub-id><?supplied-pmid 30768383?><pub-id pub-id-type="pmid">30768383</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Krebs</surname><given-names>G</given-names></string-name>, <string-name><surname>Isomura</surname><given-names>K</given-names></string-name>, <string-name><surname>Lang</surname><given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>How resistant is “treatment-resistant” obsessive-compulsive disorder in youth?</article-title><source>Br J Clin Psychol</source>. <year>2015</year>;<volume>54</volume>(<issue>1</issue>):<fpage>63</fpage>-<lpage>75</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjc.12061</pub-id><?supplied-pmid 25130442?><pub-id pub-id-type="pmid">25130442</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Aspvall</surname><given-names>K</given-names></string-name>, <string-name><surname>Andrén</surname><given-names>P</given-names></string-name>, <string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Mataix-Cols</surname><given-names>D</given-names></string-name>, <string-name><surname>Serlachius</surname><given-names>E</given-names></string-name></person-group>. <article-title>Internet-delivered cognitive behavioural therapy for young children with obsessive-compulsive disorder: development and initial evaluation of the BIP OCD Junior programme</article-title>. <source>BJPsych Open</source>. <year>2018</year>;<volume>4</volume>(<issue>3</issue>):<fpage>106</fpage>-<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1192/bjo.2018.10</pub-id><?supplied-pmid 29971153?><pub-id pub-id-type="pmid">29971153</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Vigerland</surname><given-names>S</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <etal/></person-group>. <article-title>Internet-delivered cognitive behavior therapy for adolescents with obsessive-compulsive disorder: an open trial</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>6</issue>):<elocation-id>e100773</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0100773</pub-id><?supplied-pmid 24949622?><pub-id pub-id-type="pmid">24949622</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Aspvall</surname><given-names>K</given-names></string-name>, <string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Melin</surname><given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Implementation of internet-delivered cognitive behaviour therapy for pediatric obsessive-compulsive disorder: lessons from clinics in Sweden, United Kingdom and Australia</article-title>. <source>Internet Interv</source>. <year>2020</year>;<volume>20</volume>:<elocation-id>100308</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.invent.2020.100308</pub-id><?supplied-pmid 32082991?><pub-id pub-id-type="pmid">32082991</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Ssegonja</surname><given-names>R</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <etal/></person-group>. <article-title>Cost-effectiveness of therapist-guided internet-delivered cognitive behaviour therapy for paediatric obsessive-compulsive disorder: results from a randomised controlled trial</article-title>. <source>BMJ Open</source>. <year>2017</year>;<volume>7</volume>(<issue>5</issue>):<elocation-id>e015246</elocation-id>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2016-015246</pub-id><?supplied-pmid 28515196?><pub-id pub-id-type="pmid">28515196</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Mataix-Cols</surname><given-names>D</given-names></string-name>, <etal/></person-group>. <article-title>Therapist-guided, internet-delivered cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled trial</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2017</year>;<volume>56</volume>(<issue>1</issue>):<fpage>10</fpage>-<lpage>19.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaac.2016.09.515</pub-id><?supplied-pmid 27993223?><pub-id pub-id-type="pmid">27993223</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Mataix-Cols</surname><given-names>D</given-names></string-name>, <string-name><surname>Rück</surname><given-names>C</given-names></string-name>, <string-name><surname>Aspvall</surname><given-names>K</given-names></string-name>, <string-name><surname>Serlachius</surname><given-names>E</given-names></string-name></person-group>. <article-title>Long-term outcomes of therapist-guided internet-delivered cognitive behavior therapy for pediatric obsessive-compulsive disorder</article-title>. <source>NPJ Digit Med</source>. <year>2020</year>;<volume>3</volume>(<issue>1</issue>):<fpage>124</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41746-020-00327-x</pub-id><?supplied-pmid 33043148?><pub-id pub-id-type="pmid">33043148</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Aspvall</surname><given-names>K</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <etal/></person-group>. <article-title>Stepped care internet-delivered vs face-to-face cognitive-behavior therapy for pediatric obsessive-compulsive disorder: a trial protocol for a randomized noninferiority trial</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>(<issue>10</issue>):<elocation-id>e1913810</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.13810</pub-id><?supplied-pmid 31642928?><pub-id pub-id-type="pmid">31642928</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Aspvall</surname><given-names>K</given-names></string-name>, <string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Melin</surname><given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Effect of an internet-delivered stepped-care program vs in-person cognitive behavioral therapy on obsessive-compulsive disorder symptoms in children and adolescents: a randomized clinical trial</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>325</volume>(<issue>18</issue>):<fpage>1863</fpage>-<lpage>1873</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2021.3839</pub-id><?supplied-pmid 33974020?><pub-id pub-id-type="pmid">33974020</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Husereau</surname><given-names>D</given-names></string-name>, <string-name><surname>Drummond</surname><given-names>M</given-names></string-name>, <string-name><surname>Petrou</surname><given-names>S</given-names></string-name>, <etal/>; <collab>ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force</collab></person-group>. <article-title>Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force</article-title>. <source>Value Health</source>. <year>2013</year>;<volume>16</volume>(<issue>2</issue>):<fpage>231</fpage>-<lpage>250</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jval.2013.02.002</pub-id><?supplied-pmid 23538175?><pub-id pub-id-type="pmid">23538175</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r24">
                <label>24</label>
                <mixed-citation publication-type="book"><person-group><collab>American Psychiatric Association</collab></person-group>. <source>Diagnostic and Statistical Manual of Mental Disorders.</source><edition>5th ed</edition>. <publisher-name>American Psychiatric Association</publisher-name>; <year>2013</year>.</mixed-citation>
              </ref>
              <ref id="zoi210551r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Scahill</surname><given-names>L</given-names></string-name>, <string-name><surname>Riddle</surname><given-names>MA</given-names></string-name>, <string-name><surname>McSwiggin-Hardin</surname><given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1997</year>;<volume>36</volume>(<issue>6</issue>):<fpage>844</fpage>-<lpage>852</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00004583-199706000-00023</pub-id><?supplied-pmid 9183141?><pub-id pub-id-type="pmid">9183141</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mataix-Cols</surname><given-names>D</given-names></string-name>, <string-name><surname>Fernández de la Cruz</surname><given-names>L</given-names></string-name>, <string-name><surname>Nordsletten</surname><given-names>AE</given-names></string-name>, <string-name><surname>Lenhard</surname><given-names>F</given-names></string-name>, <string-name><surname>Isomura</surname><given-names>K</given-names></string-name>, <string-name><surname>Simpson</surname><given-names>HB</given-names></string-name></person-group>. <article-title>Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder</article-title>. <source>World Psychiatry</source>. <year>2016</year>;<volume>15</volume>(<issue>1</issue>):<fpage>80</fpage>-<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1002/wps.20299</pub-id><?supplied-pmid 26833615?><pub-id pub-id-type="pmid">26833615</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Turner</surname><given-names>CM</given-names></string-name>, <string-name><surname>Mataix-Cols</surname><given-names>D</given-names></string-name>, <string-name><surname>Lovell</surname><given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled non-inferiority trial</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2014</year>;<volume>53</volume>(<issue>12</issue>):<fpage>1298</fpage>-<lpage>1307.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jaac.2014.09.012</pub-id><?supplied-pmid 25457928?><pub-id pub-id-type="pmid">25457928</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sanders</surname><given-names>GD</given-names></string-name>, <string-name><surname>Neumann</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Basu</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>316</volume>(<issue>10</issue>):<fpage>1093</fpage>-<lpage>1103</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2016.12195</pub-id><?supplied-pmid 27623463?><pub-id pub-id-type="pmid">27623463</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r29">
                <label>29</label>
                <mixed-citation publication-type="book">Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. <italic>Cost-Effectiveness in Health and Medicine</italic>. 2nd ed. Oxford University Press; 2017.</mixed-citation>
              </ref>
              <ref id="zoi210551r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bouwmans</surname><given-names>C</given-names></string-name>, <string-name><surname>De Jong</surname><given-names>K</given-names></string-name>, <string-name><surname>Timman</surname><given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P)</article-title>. <source>BMC Health Serv Res</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>):<fpage>217</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1472-6963-13-217</pub-id><?supplied-pmid 23768141?><pub-id pub-id-type="pmid">23768141</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r31">
                <label>31</label>
                <mixed-citation publication-type="web"><person-group><collab>Organisation for Economic Co-operation and Development</collab></person-group>. CCEMG—EPPI-Centre cost converter. Accessed October 20, 2020. <ext-link ext-link-type="uri" xlink:href="http://eppi.ioe.ac.uk/costconversion/">http://eppi.ioe.ac.uk/costconversion/</ext-link></mixed-citation>
              </ref>
              <ref id="zoi210551r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Stevens</surname><given-names>K</given-names></string-name></person-group>. <article-title>Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation</article-title>. <source>Appl Health Econ Health Policy</source>. <year>2011</year>;<volume>9</volume>(<issue>3</issue>):<fpage>157</fpage>-<lpage>169</lpage>. doi:<pub-id pub-id-type="doi">10.2165/11587350-000000000-00000</pub-id><?supplied-pmid 21506622?><pub-id pub-id-type="pmid">21506622</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Matthews</surname><given-names>JNS</given-names></string-name>, <string-name><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Royston</surname><given-names>P</given-names></string-name></person-group>. <article-title>Analysis of serial measurements in medical research</article-title>. <source>BMJ</source>. <year>1990</year>;<volume>300</volume>(<issue>6719</issue>):<fpage>230</fpage>-<lpage>235</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.300.6719.230</pub-id><?supplied-pmid 2106931?><pub-id pub-id-type="pmid">2106931</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Schafer</surname><given-names>JL</given-names></string-name>, <string-name><surname>Graham</surname><given-names>JW</given-names></string-name></person-group>. <article-title>Missing data: our view of the state of the art</article-title>. <source>Psychol Methods</source>. <year>2002</year>;<volume>7</volume>(<issue>2</issue>):<fpage>147</fpage>-<lpage>177</lpage>. doi:<pub-id pub-id-type="doi">10.1037/1082-989X.7.2.147</pub-id><?supplied-pmid 12090408?><pub-id pub-id-type="pmid">12090408</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Barber</surname><given-names>J</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>S</given-names></string-name></person-group>. <article-title>Multiple regression of cost data: use of generalised linear models</article-title>. <source>J Health Serv Res Policy</source>. <year>2004</year>;<volume>9</volume>(<issue>4</issue>):<fpage>197</fpage>-<lpage>204</lpage>. doi:<pub-id pub-id-type="doi">10.1258/1355819042250249</pub-id><?supplied-pmid 15509405?><pub-id pub-id-type="pmid">15509405</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Manca</surname><given-names>A</given-names></string-name>, <string-name><surname>Hawkins</surname><given-names>N</given-names></string-name>, <string-name><surname>Sculpher</surname><given-names>MJ</given-names></string-name></person-group>. <article-title>Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility</article-title>. <source>Health Econ</source>. <year>2005</year>;<volume>14</volume>(<issue>5</issue>):<fpage>487</fpage>-<lpage>496</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hec.944</pub-id><?supplied-pmid 15497198?><pub-id pub-id-type="pmid">15497198</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r37">
                <label>37</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Drummond</surname><given-names>MF</given-names></string-name>, <string-name><surname>Sculpher</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Claxton</surname><given-names>K</given-names></string-name>, <string-name><surname>Stoddart</surname><given-names>GL</given-names></string-name>, <string-name><surname>Torrance</surname><given-names>GW</given-names></string-name></person-group>. <source>Methods for the Economic Evaluation of Health Care Programmes</source>. 4th ed. Oxford University Press; <year>2015</year>.</mixed-citation>
              </ref>
              <ref id="zoi210551r38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Andersson</surname><given-names>E</given-names></string-name>, <string-name><surname>Hedman</surname><given-names>E</given-names></string-name>, <string-name><surname>Ljótsson</surname><given-names>B</given-names></string-name>, <etal/></person-group><article-title>Cost-effectiveness of internet-based cognitive behavior therapy for obsessive-compulsive disorder: results from a randomized controlled trial</article-title>. <source>J Obsessive Compuls Relat Disord.</source><year>2015</year>;<volume>4</volume>:<fpage>47</fpage>-<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jocrd.2014.12.004</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Chatterton</surname><given-names>ML</given-names></string-name>, <string-name><surname>Rapee</surname><given-names>RM</given-names></string-name>, <string-name><surname>Catchpool</surname><given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Economic evaluation of stepped care for the management of childhood anxiety disorders: results from a randomised trial</article-title>. <source>Aust N Z J Psychiatry</source>. <year>2019</year>;<volume>53</volume>(<issue>7</issue>):<fpage>673</fpage>-<lpage>682</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0004867418823272</pub-id><?supplied-pmid 30658546?><pub-id pub-id-type="pmid">30658546</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>van den Brink</surname><given-names>M</given-names></string-name>, <string-name><surname>van den Hout</surname><given-names>WB</given-names></string-name>, <string-name><surname>Stiggelbout</surname><given-names>AM</given-names></string-name>, <string-name><surname>Putter</surname><given-names>H</given-names></string-name>, <string-name><surname>van de Velde</surname><given-names>CJH</given-names></string-name>, <string-name><surname>Kievit</surname><given-names>J</given-names></string-name></person-group>. <article-title>Self-reports of health-care utilization: diary or questionnaire?</article-title><source>Int J Technol Assess Health Care</source>. <year>2005</year>;<volume>21</volume>(<issue>3</issue>):<fpage>298</fpage>-<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0266462305050397</pub-id><?supplied-pmid 16110708?><pub-id pub-id-type="pmid">16110708</pub-id></mixed-citation>
              </ref>
              <ref id="zoi210551r41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>van Lier</surname><given-names>LI</given-names></string-name>, <string-name><surname>Bosmans</surname><given-names>JE</given-names></string-name>, <string-name><surname>van Hout</surname><given-names>HPJ</given-names></string-name>, <etal/></person-group>. <article-title>Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study</article-title>. <source>Eur J Health Econ</source>. <year>2018</year>;<volume>19</volume>(<issue>7</issue>):<fpage>993</fpage>-<lpage>1008</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10198-017-0947-x</pub-id><?supplied-pmid 29260341?><pub-id pub-id-type="pmid">29260341</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZOI210551-1">
              <supplementary-material content-type="local-data" id="note-ZOI210551-1-s">
                <label>Supplement.</label>
                <caption>
                  <p><bold>eMethods.</bold> Costs (Continued)</p>
                  <p><bold>eFigure 1.</bold> Flow Chart</p>
                  <p><bold>eFigure 2.</bold> Cost-effectiveness Planes Using Remitter Status and QALYs as Secondary Health Outcomes</p>
                  <p><bold>eTable.</bold> Therapist Time</p>
                  <p>eReferences.</p>
                </caption>
                <media xlink:href="jamanetwopen-e2118516-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
